Skip to main navigation Skip to search Skip to main content

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

Translated title of the contribution: No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
  • M.L. Grijsen
  • , R. Steingrover
  • , F.W.N.M. Wit
  • , X et al
  • , A.I.M. Hoepelman
  • , T. Mudrikova
  • , I. Kroon
  • , J.M. Prins

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionNo treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
Original languageUndefined/Unknown
Pages (from-to)e1001196
Number of pages1
JournalPLoS Medicine
Volume18
Issue number4
Publication statusPublished - 2012

Cite this